Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL) reported to Hong Kong Exchanges and Clearing that there were no movements in either authorised or issued share capital during April 2026.

Total authorised/registered share capital remained at RMB 383.57 million, comprising:

• H shares: 95.14 million ordinary shares listed in Hong Kong, par value RMB 1.00 each. • A shares: 288.43 million ordinary shares listed on the Shanghai Stock Exchange, par value RMB 1.00 each.

Issued share figures were unchanged from the previous month:

• H shares in issue: 95.14 million; no treasury shares were held. • A shares in issue (excluding treasury): 287.05 million, while 1.38 million A shares continued to be held as treasury stock.

The company confirmed compliance with the Hong Kong Listing Rules’ minimum public-float requirement for its H-share class as at 30 April 2026.

No share options, warrants, convertibles or other equity instruments were outstanding or exercised, and no additional agreements to issue shares were disclosed for the period.

The monthly return was submitted on 6 May 2026 by Company Secretary Ip Pui Sum.